Core Insights - The "Wave Peak Plan" launched by the Zhituo Finance's think tank, Pengpai Research Institute, aims to promote industrial collaboration and technological innovation in the Yangtze River Delta region [1] Industry Highlights - Shanghai is supporting the G60 Science and Technology Innovation Corridor to reach a world-class level [1] - Nanjing has completed its annual target for attracting investment in the artificial intelligence and software industries ahead of schedule [1] - Hangzhou has opened a national medical AI pilot base in Xiaoshan [1] - Hefei has released the first batch of financial application scenarios exceeding 30 billion yuan [1] - Suzhou is accelerating the development of the industrial mother machine industry in Taicang [1] - Ningbo's new energy vehicle exports surged nearly threefold in the first eleven months [1] - Wuxi is deepening cooperation with Shanghai in AI and new energy industries [1] - Nantong's foreign trade exceeded 400 billion yuan for the first time in the first eleven months [1] - Changzhou has established the first overseas OPC international community [1]

Core Insights - The "Wave Plan" launched by the Zhituo Finance's think tank, Pengpai Research Institute, aims to promote industrial collaboration and technological innovation in the Yangtze River Delta region [1] Industry Highlights - Shanghai is focusing on the G60 Science and Technology Innovation Corridor, targeting two major industries to achieve world-class status [1] - Nanjing is accelerating the establishment of more "Hema Village" direct supply bases [1] - Hangzhou is striving to develop the "China Vision Valley" into a trillion-yuan visual intelligence cluster [1] - Hefei has a significant presence in quantum enterprises, accounting for one-third of the national total [1] - Suzhou is deepening cooperation with Singapore to build a 600 billion yuan industrial cluster [1] - Ningbo's Cixi home appliance industry is rapidly transitioning to smart manufacturing, aiming to cultivate export brands [1] - Wuxi has seen a concentration of innovative pharmaceutical companies receiving approvals, with new Class I and Class III drugs being launched [1] - Nantong is collaborating with provincial coastal groups to establish a marine industry characteristic park [1] - Changzhou's Kangyuan Group is setting up a biopharmaceutical innovation base in Xitai Lake [1]